Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,665,113
-$3,484,533 QoQ
Shares Held
93,689
-64.6% QoQ
Ownership
0.502%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 156 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. RIGL ranks #188 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RIGL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,665,113 | 93,689 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,149,646 | 264,410 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,479,431 | 431,460 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,983,177 | 105,301 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $585,481 | 31,259 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $1,184,565 | 70,426 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $349,078 | 42,467 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,772,022 | 1,872,988 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,124,963 | 775,837 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,361,074 | 3,112,106 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,799,526 | 4,495,757 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,912,994 | 5,237,117 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,782,417 | 3,188,278 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,499,466 | 7,202,938 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $708,105 | 626,642 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,473,445 | 2,499,480 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,049,202 | 4,546,869 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,701,224 | 4,049,924 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,092,390 | 4,629,583 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,581,342 | 3,678,755 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,599,680 | 1,028,480 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,521,220 | 633,842 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,032,648 | 564,289 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $12,735,822 | 8,163,989 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||